Many studies have demonstrated the pro‐sclerotic role of CTGF in peritoneal fibrosis during PD because the dialysate CTGF concentration could be a biomarker for peritoneal fibrosis. This evidence concerns the gene CCN2 and Peritoneal Fibrosis.